Skip to main content

Nektar Therapeutics (NASDAQ: NKTR) Investor Securities Class Action Lawsuit 03/06/2026

  • If you purchased a significant amount of shares of Nektar Therapeutics (NASDAQ: NKTR) between February 26, 2025 and December 15, 2025, and / or if you purchased any NASDAQ: NKTR shares prior to February 2025 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: May 5, 2026. NASDAQ: NKTR investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

March 06, 2026 - An investor in shares of Nektar Therapeutics (NASDAQ: NKTR) filed a lawsuit in the U.S. District Court for the Northern District of California over alleged violations of Federal Securities Laws by Nektar Therapeutics in connection with certain allegedly false and misleading statements made between February 26, 2025 and December 15, 2025.   San Francisco, CA based Nekt...



You must register (for free) or login to view the entire case.